Rhoshan Pharmaceuticals, Inc.
PrivateLast Round
Seed Round
Jul 22, 2026
Total Funding Raised
$5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rhoshan Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing injectable versions of commonly used oral drugs to provide essential early treatment for acute, life-threatening conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhoshan Pharmaceuticals, Inc. Comparables
Compare Rhoshan Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nevakar Inc. | 78% | |
| Hyloris Pharmaceuticals | 77% | |
| Cumberland Pharmaceuticals Inc. | 67% | |
Rhoshan Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 22, 2026 | ||||
| VC Round | Sep 18, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Raised $3.1M in seed funding.
- Sep 18, 2023
$3.1M raised in a VC Round.
Rhoshan Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rhoshan Pharmaceuticals, Inc.'s valuation, stock price, and market status.